Clinical Trials Logo

Healthy Participants clinical trials

View clinical trials related to Healthy Participants.

Filter by:

NCT ID: NCT04994106 Completed - Clinical trials for Healthy Participants

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD5462 Following Single and Multiple Ascending Dose Administration to Healthy Volunteers

Start date: July 27, 2021
Phase: Phase 1
Study type: Interventional

This study will assess the safety, tolerability, and pharmacokinetic (PK) of AZD5462 following single ascending dose (SAD) and multiple ascending dose (MAD) administration in healthy male and female participants and healthy participants of Japanese descent.

NCT ID: NCT04987177 Completed - Clinical trials for Healthy Participants

Effect of Manual Wheelchair Propulsion Workload on Speed, Energy Expenditure, and Propulsion Mechanics

Start date: August 7, 2021
Phase: N/A
Study type: Interventional

The first purpose of this study is to characterize the relationship among propulsion workload, self-selected propulsion speed, and propulsion kinetics/kinematics. The second purpose is to assess the between days repeatability/reliability of the above outcomes. There are no hypothesis This is a repeated measures clinical trial. All participants will complete the following: 1) Acclimation to propelling a manual wheelchair on a wheelchair ergometer; 2) Graded exercise test on the wheelchair ergometer to 80% of age adjusted estimated maximal heart rate; and 3) N=20 one minute propulsion bouts on the wheelchair ergometer.

NCT ID: NCT04973839 Recruiting - Clinical trials for Healthy Participants

Optimizing the Efficacy of Progressive Muscle Relaxation Using Placebo Mechanisms in an Guided and Unguided Online-intervention

Start date: July 7, 2021
Phase: N/A
Study type: Interventional

This study aims to determine whether a brief video aiming to optimize expectations regarding the effectiveness of progressive muscle relaxation (PMR) can enhance the efficacy of a PMR compared to a neutral video control group in an online intervention. Another aim is to assess whether this effect will be moderated by the degree of human support (guided or unguided intervention).

NCT ID: NCT04971395 Completed - Clinical trials for Healthy Participants

Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Infusion of XTMAB-16 in Healthy Adult Participants

Start date: June 25, 2021
Phase: Phase 1
Study type: Interventional

This is a single-center, randomized, double-blind, placebo-controlled, first-in-human, single intravenous (IV) infusion of XTMAB-16 (formerly referred to as KBMAB-16) in normal healthy male and female participants.

NCT ID: NCT04970407 Completed - Clinical trials for Healthy Participants

A Comparative Study to Evaluate the Effects and Mechanism of Action of Dysport®, Botox® and Xeomin® in the Extensor Digitorum Brevis Model in Healthy Adult Male Participants

Start date: July 6, 2021
Phase: Phase 1
Study type: Interventional

Study aimed at comparing the pharmacodynamic profile (including duration of action) of three commercialized toxins by measuring the action potential of the injected muscle (extensor digitorum brevis)

NCT ID: NCT04961645 Recruiting - Clinical trials for Healthy Participants

Brain Stimulation and Visually-guided Navigation

Start date: March 3, 2023
Phase: N/A
Study type: Interventional

This study investigates the neural mechanisms causally involved in how people navigate through their immediately visible environment (e.g., walking around one's bedroom flawlessly and effortlessly, not bumping into the walls or furniture). To investigate whether particular neural mechanisms are causally involved in "visually-guided navigation", repetitive transcranial magnetic stimulation (rTMS) is used to temporarily disrupt the functioning of particular brain regions in healthy adults while they are shown simple visual stimuli of places (e.g., bedrooms, kitchens, and living rooms) and asked to perform simple computer tasks or to complete simple behavioral tasks.

NCT ID: NCT04961255 Recruiting - Clinical trials for Healthy Participants

Effects of Post-COVID-19 on Quadriceps Femoral Muscle-tendon Unit

Start date: August 24, 2021
Phase:
Study type: Observational

The physiological/biomechanical characteristics related to muscle and tendon architecture and their possible relationship with the loss of muscle strength and fatigue in patients who were infected with COVID-19 are totally unknown. The aim of this study is to evaluate inflammatory markers, the isometric maximum voluntary force of the knee extensor torque, muscle fatigue, neuromuscular adaptations, muscle architecture, tendinous properties of quadriceps components, oxygen extraction, and body composition in participants after diagnosis with Covid-19 who had moderate and severe levels of involvement compared to a healthy control group.

NCT ID: NCT04956627 Completed - Clinical trials for Healthy Participants

A Study to Assess the Effect of Itraconazole, Phenytoin and Gemfibrozil on the Drug Levels of BMS-986166 in Healthy Participants

Start date: July 28, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the effect of itraconazole, phenytoin and gemfibrozil on the drug levels of BMS-986166 and its active metabolite BMT-121795. Participants will be randomly assigned to one of four groups and will remain in the study clinic for the duration of treatment.

NCT ID: NCT04950595 Not yet recruiting - Clinical trials for Healthy Participants

Plant-based Mince vs Beef Mince: Does One Make You Feel Fuller for Longer?

Start date: August 2021
Phase: Phase 2
Study type: Interventional

This project will provide preliminary evidence to support whether V2 plant-based mince could contribute to increased satiety following a meal, which may assist in a weight reduction dietary regime when substituted for standard beef mince.

NCT ID: NCT04949269 Completed - Clinical trials for Healthy Participants

A Study to Evaluate the Drug Levels of Deucravacitinib From Tablets After Oral Administration in Healthy Participants

Start date: July 20, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the drug levels of deucravacitinib after oral administration in healthy participants.